Evidence map›Paper›PMID 40928152›Full record

ArticleChemSusChem2025

Boosting POM-Ionosolv Biorefining of Lignocellulosic Biomass by Using Redox-Balanced Polyoxometalate Catalysts in Methanolic Ionic Liquid Reaction Media.

Stefanie Wesinger, Aleksandra Rabiner, Suhaib Nisar, Leonhard Schill, Mariusz Grzegorz Kubus, Maximilian J Poller, Anders Riisager, Agnieszka Brandt-Talbot, Jason P Hallett, Jakob Albert

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefanie WesingerInstitute of Technical and Macromolecular Chemistry, University of Hamburg, Bundesstraße 45, 20146, Hamburg, Germany.
Aleksandra RabinerDepartment of Chemical Engineering, Imperial College London, Bone Building, South Kensington Campus, London, SW7 2AZ, UK.
Suhaib NisarDepartment of Chemical Engineering, Imperial College London, Bone Building, South Kensington Campus, London, SW7 2AZ, UK.
Leonhard SchillDepartment of Chemistry, Technical University of Denmark, Kemitorvet, 207, 2800, Kgs. Lyngby, Denmark.
Mariusz Grzegorz KubusDepartment of Chemistry, Technical University of Denmark, Kemitorvet, 207, 2800, Kgs. Lyngby, Denmark.
Maximilian J PollerInstitute of Technical and Macromolecular Chemistry, University of Hamburg, Bundesstraße 45, 20146, Hamburg, Germany.
Anders RiisagerDepartment of Chemistry, Technical University of Denmark, Kemitorvet, 207, 2800, Kgs. Lyngby, Denmark.
Agnieszka Brandt-TalbotDepartment of Chemistry, Imperial College London, Molecular Sciences Research Hub, White City Campus, 82 Wood Lane, W12 0BZ, UK.
Jason P HallettDepartment of Chemical Engineering, Imperial College London, Bone Building, South Kensington Campus, London, SW7 2AZ, UK.
Jakob AlbertInstitute of Technical and Macromolecular Chemistry, University of Hamburg, Bundesstraße 45, 20146, Hamburg, Germany.ORCID https://orcid.org/0000-0002-3923-2269

Funding

University of Hamburg
6 · The paper itself

Abstract

This article presents an advanced iteration of the polyoxometalate (POM)-Ionosolv concept to generate biobased methyl formate in high yield and a bleached cellulose pulp from lignocellulosic biomass in a single-step operation by using redox-balanced POM catalysts and molecular oxygen in alcoholic ionic liquid (IL) mixtures. The performance of the three Ionosolv-ILs triethylammonium hydrogen sulfate ([TEA][HSO

Indexed as

cellulose pulpgreen chemistrylignocellulosic biomassmethyl formatepolyoxometalatepolyoxometalate‐ionosolv biorefining

Identifiers

PMID40928152
PMCPMC12548942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.